Pneumococcal vaccine (Prevnar) for otitis media
Medical Letter on Drugs and Therapeutics 45(1153): 27-28
2003
ISSN/ISBN: 0025-732X PMID: 12663966 Document Number: 565832
Document emailed within 1 workday
Related Documents
Mäkelä, P.H.; Karma, P. 1980: Can otitis media be prevented with pneumococcal vaccine? Progress in Clinical and Biological Research 47: 95-106Douglas, R.M.; Miles, H.; Hansman, D.; Moore, B.; English, D.T. 1980: Microbiology of acute otitis media with particular reference to the feasibility of pneumococcal immunization Medical Journal of Australia 1(6): 263-266
Shimada, J. 2001: Transmission of pneumococcal otitis media within siblings and drug sensitivity of the pathogen Japanese Journal of Antibiotics 54 Suppl B: 109
Solignac, M. 1998: Pneumococcal resistance to beta-lactams: implications for the treatment of acute otitis media Presse Medicale 27(Suppl 3): 31-34
Doherty, M.J.; Greenstone, M.A.; Meigh, R. 1997: Pneumococcal vaccine campaign based in general practice. Small audit showed that only 14% of patients were offered pneumococcal vaccine Bmj 315(7111): 816
Vyse, A.; Campling, J.; Czudek, C.; Ellsbury, G.; Slack, M. 2020: The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development Vaccine 38(51): 8068-8070
Sun, X.-w.; Zhang, J.-j.; Ding, Y.-p.; Dou, F.-f.; Zhang, H.-b.; Gong, K.-b.; Xu, A.-t. 2011: Efficacy of high-resolution CT in differential diagnosis of chronic suppurative otitis media and cholesteatoma otitis media by soft-tissue shadows Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46(5): 388-392
Gomezbarreto, D.; De la Torregonzalez, C.; Jimenezvelazquez, A.; Alvarezneri, H. 1997: Otitis media aguda. Tratamiento médico - Medical treatment of acute otitis media Boletin Medico del Hospital Infantil de Mexico (Ed. Espanola) 54(11): 556-565
1996: Belgian consensus on pneumococcal vaccine. Working Party on Pneumococcal Vaccine Acta Clinica Belgica 51(5): 350-356
Vernacchio, L.; Neufeld, E.J.; Macdonald, K.; Kurth, S.; Murakami, S.; Hohne, C.; King, M.; Molrine, D. 1998: Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease Journal of Pediatrics 133(2): 275-278
Raikundalia, K.B. 1975: Analysis of suppurative otitis media in children: aetiology of non-suppurative otitis media Medical Journal of Australia 1(24): 749-750
Herberts, G.; Jeppsson, P.H.; Nylén, O.; Branefors-Helander, P. 1971: Acute otitis media. Etiological and therapeutical aspects on acute otitis media Practica Oto-Rhino-Laryngologica 33(3): 191-202
Aker, M.; Amitai, I.; Hass, H. 1983: Failure of pneumococcal vaccine to prevent pneumococcal meningitis Harefuah 105(7): 164
Brandstetter, R.D.; Kaplowitz, I.; Pugliese, A.; Andresen, A.; Phillips, E. 1991: Fatal pneumococcal infection: another plea for the pneumococcal vaccine New York State Journal of Medicine 91(1): 36
Stangerup, S.E.; Tos, M. 1985: The etiologic role of acute suppurative otitis media in chronic secretory otitis American Journal of Otology 6(2): 126-131
Deguchi, K.; Yokota, N.; Koguchi, M.; Suzuki, Y.; Fukayama, S.; Ishihara, R.; Oda, S. 1993: Antibacterial activities of cefmenoxime against recent clinical isolates from patients of otitis media and otitis externa Japanese Journal of Antibiotics 46(10): 850-859
Sumitsawan, Y.; Tharavichitkul, P.; Prawatmuang, W.; Ingsuwan, B.; Sriburi, P. 1995: Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa Journal of the Medical Association of Thailand 78(9): 455-459
Cohen, D. 1990: Secretory otitis media with malignant external otitis American Journal of Otology 11(3): 207-208
Austrian, R. 1988: Correction: pneumococcal vaccine and pneumococcal pneumonia Annals of Internal Medicine 109(9): 762-763
Lue, C.; Tarkowski, A.; Mestecky, J. 1988: Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies Journal of Immunology 140(11): 3793-3800